The molecular basis of myocardial adaptation to ischemia and reperfusion is poorly understood. It is thought that nuclear proto-oncogenes act as third messengers, converting cytoplasmic signal transduction into long-term changes of gene expression. We studied the expression of six nuclear proto-oncogenes (Egr-1, c-fos, fosB, c-jun, junB, and c-myc) in myocardium subjected to ischemia and reperfusion in anesthetized pigs. Stunning was achieved by two 10-minute left anterior descending coronary artery occlusions separated by 30 minutes of reperfusion. Hearts were excised after the first occlusion, after the first reperfusion, and at 30, 120, 150, and 210 minutes of reperfusion after the second occlusion. Total RNA was prepared from stunned as well as normally perfused myocardial tissue and subjected to Northern blotting. The response of the six nuclear proto-oncogenes varied.fosB gene expression was never detected. The c-myc gene was expressed, but its level was unchanged by ischemia. c-jun expression was slightly increased by ischemia (3.1±0.6-fold). The c-fos, Egr-1, andjunB genes were highly induced, being fivefold to sevenfold higher in experimental than in control tissue. In three animals pretreated with the f11-antagonist metoprolol and then subjected to the above experimental protocol, the induction of proto-oncogenes was similar to that in nonblocked controls. Our results show that the myocardial adaptive response to ischemic stress includes the induction of at least four transcription factors that may be further operative in repair processes and angiogenesis. (Circulation Research 1992;71:1351-1360 KEY WoRDs * stunned myocardium * ischemia pig hearts S everal adaptive mechanisms of the heart in the maintenance of viability during relative oxygen supply-demand mismatch are described.' A brief coronary occlusion followed by reperfusion in dogs produces a sustained reversible contractile dysfunction termed "myocardial stunning."2 Repeated episodes of brief ischemia with intermittent reperfusion do not produce cumulative injury3-5 but rather increase myocardial resistance to ischemia and infarction after a subsequent longer period of coronary occlusion.6 Chronic ischemia induces increased expression of several growth factor genes7'8 and activation of mitotic growth in coronary endothelial cells,9 leading to collateral growth.10 The molecular mechanisms underlying these different types of myocardial responses to ischemia are largely unknown.
S everal adaptive mechanisms of the heart in the maintenance of viability during relative oxygen supply-demand mismatch are described.' A brief coronary occlusion followed by reperfusion in dogs produces a sustained reversible contractile dysfunction termed "myocardial stunning."2 Repeated episodes of brief ischemia with intermittent reperfusion do not produce cumulative injury3-5 but rather increase myocardial resistance to ischemia and infarction after a subsequent longer period of coronary occlusion. 6 Chronic ischemia induces increased expression of several growth factor genes7'8 and activation of mitotic growth in coronary endothelial cells,9 leading to collateral growth.10 The molecular mechanisms underlying these different types of myocardial responses to ischemia are largely unknown.
The molecular responses of eukaryotic cells to environmental changes like growth factor stimulation, membrane depolarization, and stress-inducing agents are complex and involve the rapid expression of at least Krox-2422), codes for a structurally unrelated protein that has three zinc finger domains, by which it specifically interacts with DNA.'9 All the above mentioned genes code for proteins (located in the nucleus) that bind to cis-regulatory sequences of other genes by activating or repressing expression. 23 Using our previously described model of swine myocardium subjected to two periods of left anterior descending coronary artery (LAD) occlusion and reperfusion,6 we investigated whether ischemic stress alters myocardial gene expression. In this regard, we have isolated total RNA from ischemic and normally perfused myocardium at different time points during the experimental protocol. Northern blots were prepared and hybridized with six cDNA probes for nuclear proto-oncogenes. In addition, to test whether norepinephrine release after ischemia and reperfusion is important for the induction of nuclear proto-oncogenes, we included the results from three animals after administration of the /3-adrenergic antagonist metoprolol. 
Animal Preparation
Twenty-seven crossbred LandracexYorkshire pigs (H.V.C. Hedel, The Netherlands) of either sex (22-40 kg) were fasted overnight and then sedated with an intramuscular injection of 2-3 mg/kg azaperone (Stresnil, Janssen Pharmaceutica, Beerse, Belgium). They were then anesthetized with an intravenous injection of 20 mg/kg pentobarbital sodium ( Sensodyn micromanometer-tipped catheter (B. Braun Medical B.V., Uden, The Netherlands) was inserted into the left ventricle to measure left ventricular blood pressure and its first derivative (LV dP/dt). An 8F catheter was inserted into the aorta to record the central aortic blood pressure (50 AD pressure transducer, Spectramed, Bilthoven, The Netherlands) and to collect blood samples for the determination of arterial blood gases. After a midsternal thoracotomy, the heart was suspended in a pericardial cradle, and the second left rib was removed to ease further instrumentation.
Regional Myocardial Contractile Function
Regional myocardial function was estimated from recordings of myocardial wall thickness obtained with sonomicrometry (model 120, Triton Technology, San Diego, Calif.). Two pairs of ultrasonic crystals were implanted, one pair in the area perfused by the LAD and another pair in the area perfused by the left circumflex coronary artery (LCx). Of each pair, one crystal (4 mm in diameter) attached to a Dacron patch was sutured onto the epicardial surface, and the other crystal (2 mm in diameter) was inserted tangentially through the myocardium and positioned in the subendocardial layer underneath the epicardial crystal. The correct position of the crystals was confirmed at the end of each experiment. From the tracings, the end-diastolic wall thickness (EDT) and the end-systolic wall thickness (EST) were measured, and systolic wall thickening (SWT) was calculated: SWT(%)=100x(EST-EDT)/EDT.
Experimental Protocol
The experimental design is depicted in Figure 1 .
After instrumentation and stabilization for at least 30 minutes, systemic hemodynamics and regional myocardial wall thickness were recorded. Subsequently, in 15 animals the LAD just distal to its first diagonal branch was completely occluded by an arterial clamp for 10 minutes, followed by 30 minutes of reperfusion. This cycle of occlusion and reperfusion was then repeated, with systemic hemodynamics and myocardial wall thickness being recorded regularly throughout the experimental protocol. After 30 minutes of the second reperfusion period, the heart was excised in four animals. Tissues from the LAD area (ischemic area) and the LCx area (nonischemic control area) were removed. In five animals, 90 minutes of additional reperfusion was allowed (total duration of second reperfusion period, 120 minutes) before the heart was excised. Additionally, in one animal, 120 minutes of additional reperfusion was allowed (total duration, 150 minutes). In five more animals, 180 minutes of additional reperfusion was allowed (total duration, 210 minutes). The effect of 10 minutes of occlusion and 30 minutes of reperfusion was studied in three animals, and the effect of 10 minutes of occlusion alone was studied in one animal. The effect of the surgical procedures on the induction of gene expression was assessed in two control animals. These animals received all of the surgical treatment of the experimental group of animals, including the implantation of ultrasonic crystals in LAD-and LCx-perfused areas, which were designated as ischemic and nonischemic areas, respectively, in sham-operated animals. Dissection of the LAD was included in the sham operation. The sham-operated control animals were then exposed to 80 minutes of normal myocardial perfusion. To investigate the involvement of the 3-adrenergic system in the ischemia/reperfusion-induced changes, three animals were pretreated with the 831-selective adrenoceptor antagonist metoprolol (Selokeen, Astra Pharmaceuticals B.V., Rijswijk, The Netherlands). The drug was given for 3 minutes as an intravenous bolus of 0.5 mg/kg, followed by a continuous intravenous infusion of 0.5 mg/kg per hour. Fifteen minutes after the onset of the administration of metoprolol, the animals underwent the above occlusion and reperfusion cycles. No antiarrhythmic drugs were administered. Ventricular fibrillation occurred in a total of six pigs and was treated successfully (within 30 seconds) with direct current (DC) countershock. The paddles were positioned along the right ventricular and posterior walls, well away from the anterior and lateral myocardium. The effects of ventricular fibrillation and its treatment by DC countershock on proto-oncogene expression was evaluated in three animals in which ventricular fibrillation was induced with a 9-V DC battery. Subsequently (within 1 minute), the heart was defibrillated with one DC countershock (35 W). After 1 minute, this treatment of fibrillation and defibrillation was repeated one more time. One hour later, the heart was excised, and the tissue of the LAD-and LCx-perfused areas was frozen in liquid nitrogen as described in the next section.
Tissue Preparation Control areas were sampled from the lateral wall, close to the control crystals, and thus were well away from the reperfused regions. Ischemic areas were sampled within the LAD distribution, in the vicinity of the LAD crystals. This was within the central ischemic zone, as visually identified during the occlusion periods. The excised tissue was washed in 0.9% NaCl solution, blotted dry, cut down into small pieces (>0.5 cm), snap-frozen in liquid nitrogen, and stored at -80°C until further use. 
RNA Isolation and Northern Blot Analysis

Statistical Analysis
Systemic hemodynamics and myocardial contractile function were assessed by analysis of variance for repeated measures, followed by a paired two-tailed t test with the Bonferroni correction for multiple comparisons. Proto-oncogene expression was assessed by analysis of variance followed by an unpaired two-tailed t test. Statistical significance was accepted at p<0.05.
Results
Systemic Hemodynamics
The first 10 minutes of LAD occlusion caused a decrease in the mean arterial blood pressure (MAP) from 82+ 13 to 73+ 11 mm Hg and of LV dP/dtm.x from 2,050+560 to 1,600±330 mm Hg/sec. The left ventricular end-diastolic pressure (LVEDP) increased from 12±4 to 18±9 mm Hg (in all the changes,p<0.05 versus baseline); the heart rate (96±5 beats per minute) did not change (Table 1) . During the first 30 minutes of reperfusion, MAP and LVEDP recovered, but LV dP/dtmax did not. After the second occlusion, the changes in MAP and LVEDP were similar to those observed during the first occlusion, whereas LV dP/dtma, decreased further to 1,450+440 mm Hg/sec. Recovery of MAP and LVEDP was slightly less rapid after the second reperfusion than the first, but baseline values returned within 3 hours. At that point, LV dP/dt m. was 80% of the preocclusion value.
In the two control pigs, systemic hemodynamics changed by less than 5% over the 80-minute experimental period (not shown). In the three pigs given metoprolol before the experimental protocol, MAP decreased by 4±2%, heart rate decreased by 20±2%, LV dP/dtmn,, decreased by 37±6%, and LVEDP increased by 36±7% (Table 2) .
Regional Myocardial Wall Thickening
Within seconds of the first occlusion, there was a complete loss of regional systolic wall thickening in the ischemic area (from 34±7% to -3+10%, Figure 2 The three animals given metoprolol showed no change of systolic wall thickening in either ischemic or nonischemic areas, despite slight changes in end-diastolic and end-systolic thickness ( Table 3) . As in the untreated animals, within seconds there was a complete loss of systolic wall thickening in the ischemic area. Recovery was only partial during reperfusion. Expression of Nuclear Proto-oncogenes Northern blots prepared with total RNA from ischemic and nonischemic areas were hybridized with six different cDNA probes for nuclear proto-oncogenes ( Figure 3) . In sham-operated animals, all genes studied showed a 1.4-2.2-fold higher level in ischemic than in nonischemic areas ( Figure 3 and Table 4 ). After 10 minutes of ischemia (first occlusion), a strong induction of c-fos and Egr-1 was observed in the ischemic area (3.6-fold and 6.2-fold induction compared with the nonischemic area, respectively, n=l, Figure 3 ). During the first reperfusion period, c-fos and Egr-1 expression remained unchanged in relative terms (3.8±1.4-fold and 5.33± 1.9-fold, respectively, n=3); however, the absolute level of c-fos decreased (Table 4) . After the second round of occlusion and reperfusion, c-fos and Egr-1 further increased (6.8±1.4-fold and 7.8+1.9-fold, n=4, Figure 3 ). After 120 minutes of the second reperfusion, expression of both genes decreased in relative and absolute terms (c-fos, 3.1 + 1.7-fold; Egr-1, 2.6±+ 0.9-fold; n=5; Figure 3 and Table 4 ). After 150 minutes (n=1) and 210 minutes (n=5) of the second reperfusion, expression of both genes decreased to levels observed in the sham-operated animals. Expression of junB was similar to c-fos and Egr-1; however, considerable expression ofjunB mRNA was also observed in the nonischemic area after the first occlusion and after 30 minutes of the second reperfusion period. After 10 minutes of occlusion (first occlusion), junB expression increased significantly both in nonischemic and ischemic areas (Table 4) . After the first reperfusion period, expression dropped in the nonischemic area but remained high in the ischemic area (7.7+2.5-fold, n=3). In the second reperfusion period (after 30 minutes), junB expression reached its maximum level; however, because of an increased expression in the nonischemic area, it decreased relatively to 4.8±+1.6-fold (n=4). After 120, 150, and 210 minutes (n=5) of the second reperfusion, expression of junB decreased to levels observed in the sham-operated animals. In contrast to the very strong responses of c-fos, Egr-l, and junB to ischemia, c-jun showed only minor changes in expression. In the ischemic area, expression was maximum after 30 minutes of the second reperfusion, whereas the greatest difference between the ischemic and nonischemic areas was noted after the first reperfusion (3.1±0.6-fold); no significant induction was observed at any other time ( Figure 3 , Table 4 ). c-myc was expressed with a 1.5-fold difference between the ischemic and nonischemic areas throughout the time course ( Figure  4) . A higher absolute expression of c-myc was noted at Table 4 ). fosB mRNA was not detected in the ischemic pig heart (data not shown).
Six animals developed ventricular fibrillation. We were concerned that ventricular fibrillation and defibrillation by DC countershock might have induced protooncogene expression. Therefore, we studied in three animals the effect of ventricular fibrillation and DC countershocks. We found no induction of any nuclear proto-oncogene by this treatment (results not shown).
The possible involvement of the 8-adrenergic system in the ischemic induction of nuclear proto-oncogenes was tested by ,3-adrenoceptor blockade with metoprolol.
The antagonist was continuously infused but was unable to prevent the induction of c-fos, Egr-1, junB, and c-jun after coronary occlusion ( Figure 5 ). Discussion The principal finding of this study is that swine myocardium subjected to two 10-minute coronary occlusions, separated by 30 minutes of reperfusion, responds by rapid induction of nuclear proto-oncogenes Egr-1, c-fos, junB, and c-jun. The c-myc gene was also expressed with a 1.5-fold difference between the ischemic and normal perfused area; however, this difference was also observed in the sham-operated animals and was considered to be independent of the occlusion, representing the tissue response to the surgical stress inherent in our experimental design (see below). fosB was not expressed at any time point that we studied. Similar to our study, an induction of c-fos and Egr-1 has been previously observed in the ischemic kidney35 and brain. 36 The induction of nuclear proto-oncogenes in ischemic myocardium is interesting, because they encode trans-acting factors that modulate transcription of other genes.3738 The relative small changes in expression of c-jun by ischemia and reperfusion might be due to differences in the promoter structure of this gene compared with c-fos, Egr-1, and junB.39 Furthermore, junB has been shown to be a negative regulator of c-jun expression.40,4' As junB expression rises rapidly in the first reperfusion period, its protein product might inhibit the upregulation of c-jun. We detected no induction of c-myc or any expression of fosB in response to ischemia and reperfusion, which is consistent with observations in the ischemic liver. 42 The dissociation of induction of c-fos and c-myc is remarkable, because under most circumstances these genes are coinduced. 36 Nevertheless, there are a number of recent examples of an uncoupled expression of certain proto-oncogenes. Ionizing radiation induces in human epithelial cells c-jun and Egr-1 but not c-fos. 43 In cardiac development and in the aging heart, an uncoupled expression of c-myc and c-fos has been reported.44'45 The pattern of cardiac expression of nuclear proto-oncogenes in response to ischemia differs from the expression after pressure overload-, isoproterenol-, phenylephrine-, and thyroxine-induced cardiac hypertrophy,46-50 fostering the idea that different stimuli result in a different pattern of nuclear proto-oncogene induction that might suggest differences in the mechanism of stimulation.
It has been shown that the myocardium responds to diverse forms of stress by initial suppression of protein synthesis. 51, 52 This suppression is by itself a stimulus of nuclear proto-oncogene expression. In serum-stimulated cells exposed to the protein synthesis inhibitor cycloheximide, nuclear proto-oncogenes are superinduced.53 A diminished protein synthesis occurring in Occ, occlusion; Rep, reperfusion; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Tissue was taken from I and N areas at time points indicated in Figure 1 . For control purposes, the blots were also hybridized to the GAPDH cDNA probe. ischemic myocardium may thus contribute to the expression of nuclear proto-oncogenes, although it may not be the only causative factor involved. Numerous changes occur in ischemic myocardium: an increased intracellular pH, increased lactate accumulation, Ca' overload, and membrane damage,4 5 all of which may induce nuclear proto-oncogenes. Although ischemia and reperfusion cause an increased sensitivity of the f3-adrenergic receptor system and release of norepinephrine from nerve terminals,58,59 we found that 3-adrenoceptor blockade had no effect on the expression of nuclear proto-oncogenes. However, it is possible that systemic infusion of a f8-adrenergic antagonist is not sufficient to [ear proto-oncogenes. le found considerable expression of nuclear proto-)genes also in the nonischemic area. Therefore, the -ession of nuclear proto-oncogenes in the ischemic rt might be considered to be nonspecific or not ted to ischemia itself. Similar to our observation, in emic rabbit heart considerable expression of heat k protein-70 was found in the nonischemic area.611 ral different signals might be responsible for the upregulation of nuclear proto-oncogenes in the nonischemie area. First, heart muscle is a rich source of many different polypeptide growth factors that might be released under stress conditions from the isehemic area. 61 Second, it is very likely that the nonischemic region experienced an increased load as the result of the loss of contractile function of the isehemic area. Increased systolic wall stress has been shown to induce c-fos and c-jun expression in the isolated perfused rat heart.62 This factor might be experimentally excluded by using total ischemia instead of regional ischemia. Third, both the isehemic and nonischemic areas were wounded by the implantation of the ultrasonic crystals. We found considerable expression of nuclear proto-oncogene expression in the LAD territory of sham-operated animals. This might be due to the fact that the coronary artery of the LAD area was also prepared free in these animals. These manipulations might have transiently occluded the coronary artery. However, regional differences in stress sensitivity might also be responsible for the observed expression in the LAD territory.
Although we have detected augmented expression of the mRNA for nuclear proto-oncogenes, we The preconditioning effect is rapidly achieved but is lost to a large extent after 2 hours80 and is independent of any protein synthesis.8' In summary, short episodes of ischemia and reperfusion result in the increased expression of at least four nuclear proto-oncogene mRNAs. This may lead to trans-activation of genes important in repair processes of the reversibly damaged myocardium.
